EDRAMF
ICPT

Edmond de Rothschild Asset Management (France)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Edmond de Rothschild Asset Management (France)’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-33,300
Closed -$5.52M – 243
2015
Q3 		$5.52M Buy
33,300
+3,000
+10% +$660K 0.18% 102
2015
Q2 		$7.31M Buy
+30,300
New +$8.07M 0.2% 95

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Edmond de Rothschild Asset Management (France)'s ICPT Position: Q4 2015 in Review

Edmond de Rothschild Asset Management (France) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2015, closing a stake of 33,300 shares — an estimated $5.52M sold.

Edmond de Rothschild Asset Management (France) first reported a position in ICPT in Q2 2015 and held it in 2 quarters. The position peaked at $7.31M in Q2 2015. 172 funds tracked by Wall St. Rank hold ICPT as of Q4 2015.

  • Edmond de Rothschild Asset Management (France) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Edmond de Rothschild Asset Management (France) sold 33,300 Intercept Pharmaceuticals, Inc. shares in Q4 2015, an estimated $5.52M.
  • Edmond de Rothschild Asset Management (France) first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2015 and held it in 2 quarters.
  • Edmond de Rothschild Asset Management (France)'s Intercept Pharmaceuticals, Inc. position peaked at $7.31M in Q2 2015.
  • 172 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2015.

Based on Edmond de Rothschild Asset Management (France)'s 13F filing for Q4 2015, filed 16 Feb 2016.